Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Inventory (2016 - 2025)

Iradimed (IRMD) has disclosed Inventory for 13 consecutive years, with $12.2 million as the latest value for Q4 2025.

  • Quarterly Inventory rose 11.59% to $12.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.2 million through Dec 2025, up 11.59% year-over-year, with the annual reading at $12.2 million for FY2025, 11.59% up from the prior year.
  • Inventory for Q4 2025 was $12.2 million at Iradimed, down from $12.3 million in the prior quarter.
  • The five-year high for Inventory was $12.8 million in Q4 2023, with the low at $4.3 million in Q1 2022.
  • Average Inventory over 5 years is $8.6 million, with a median of $9.7 million recorded in 2023.
  • The sharpest move saw Inventory skyrocketed 128.6% in 2023, then dropped 14.91% in 2024.
  • Over 5 years, Inventory stood at $4.5 million in 2021, then increased by 25.1% to $5.6 million in 2022, then surged by 128.6% to $12.8 million in 2023, then decreased by 14.91% to $10.9 million in 2024, then grew by 11.59% to $12.2 million in 2025.
  • According to Business Quant data, Inventory over the past three periods came in at $12.2 million, $12.3 million, and $11.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.